Vivos Therapeutics (VVOS) Depreciation Expense (2020 - 2026)
Vivos Therapeutics (VVOS) reported Depreciation Expense of $300000.0 for Q1 2026, up 50.0% year-over-year from $200000.0 in Q1 2025, and up 250.0% on a QoQ basis from -$200000.0 in Q4 2025.
Vivos Therapeutics (VVOS) has 7 years of Depreciation Expense data on file, last reported at $300000.0 in Q1 2026.
- Quarterly Depreciation Expense rose 50.0% year-over-year to $300000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $800000.0 (up 60.0% YoY) and the FY2025 annual result came in at $700000.0, up 40.0% from the prior year.
- Depreciation Expense rose to $300000.0 in Q1 2026 per VVOS's latest filing, from -$200000.0 in the prior quarter.
- Across five years, Depreciation Expense topped out at $400000.0 in Q3 2025 and bottomed at -$200000.0 in Q4 2025.
- The 5-year median for Depreciation Expense is $200000.0 (2022), against an average of $170588.2.
- Peak annual rise in Depreciation Expense reached 300.0% in 2025, while the deepest fall reached 300.0% in 2025.
- Tracing VVOS's Depreciation Expense over 5 years: stood at $300000.0 in 2022, then sank by 33.33% to $200000.0 in 2023, then tumbled by 50.0% to $100000.0 in 2024, then tumbled by 300.0% to -$200000.0 in 2025, then jumped by 250.0% to $300000.0 in 2026.
- Per Business Quant, the three latest VVOS Depreciation Expense figures stand at $300000.0 (Q1 2026), -$200000.0 (Q4 2025), and $400000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | -200,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 80,597.00 |
| Mar 31, 2021 | 100,000.00 |
| Dec 31, 2020 | -14,272.00 |
| Sep 30, 2020 | 162,180.00 |
| Jun 30, 2020 | 75,881.00 |
| Mar 31, 2020 | 76,211.00 |